the benefits flowing from preventing postmenopausal osteoporosis by oestrogen replacement therapy are assessed and contrasted with the danger to life posed by endometrial adenocarcinoma : it is pointed out that the type of neoplasm developing in patients taking oestrogens is well differentiated , nonaggressive and easily cured , the survival rate being very high .
C0029458
postmenopausal osteoporosis
C0014939
oestrogens